| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 02/12/2003 | CN1396260A Ox bLATS1 gene, nucleotide, protein coding sequence and its preparing process and application |
| 02/12/2003 | CN1396259A Chicken cLATS1 gene, nucleoside, proteincoding sequence and its preparing process and application |
| 02/12/2003 | CN1396258A Recopulated strain of rotavirus gene |
| 02/12/2003 | CN1396183A Human fusion antibody for reducing cerebral amyloid fibers associated with senile dementia |
| 02/12/2003 | CN1396178A Engineered polypeptide resisting infection of coated virus (hepatitis B virus) and its preparing process |
| 02/12/2003 | CN1396176A Method for purifying drug active protein by cation exchange chromatogrphy |
| 02/12/2003 | CN1396173A Gene sequence of genital regulation factor enriched in hypothalamus of Epinephelus and its usage |
| 02/12/2003 | CN1101470C Novel nitrile hydratase |
| 02/12/2003 | CN1101469C Genes encoding enzymers of BalI restruction-modification system |
| 02/12/2003 | CN1101403C Preparation of granulocyte colony stimulation factor |
| 02/11/2003 | USRE37984 Process for analyzing length polymorphisms in DNA regions |
| 02/11/2003 | US6519583 Graphical viewer for biomolecular sequence data |
| 02/11/2003 | US6519492 Method and apparatus for direct in vivo gene transfer by electrotransfection |
| 02/11/2003 | US6518487 Isolated nucleic acid; increases transformation efficiency; use to control cell division and cell cycle regulation |
| 02/11/2003 | US6518486 Increasing mass by transformation with a gene that encodes an enzyme that is directly involved in NAD(P)H consumption |
| 02/11/2003 | US6518485 Particle-mediated conifer transformation |
| 02/11/2003 | US6518484 Promoter system of plant translationally controlled tumor protein gene |
| 02/11/2003 | US6518483 Expression of nucleotide sequence, for gene encoding Knox1, in a plant; can use to increase plant growth and disease resistance; genetic engineering |
| 02/11/2003 | US6518417 Antisense nucleic acids targeting HBV |
| 02/11/2003 | US6518416 Method of determining a chemotherapeutic regimen based on ERCC1 expression |
| 02/11/2003 | US6518414 Isolated polynucleotide molecule which encodes a polypeptide of given sequence; can be used in diagnosis/treatment of cancer and to produce antibodies |
| 02/11/2003 | US6518413 Isolated nucleic acid encoding the polypeptide which, on expression in a host cell, produces the polypeptide; use in treatment of muscular dystrophy |
| 02/11/2003 | US6518412 Gene therapy approaches to supply apolipoprotein A-I agonists and their use to treat dyslipidemic disorders |
| 02/11/2003 | US6518404 Human endothelin-bombesin receptor antibodies |
| 02/11/2003 | US6518403 Antibodies that bind an adipocyte-specific protein homolog |
| 02/11/2003 | US6518402 Antibodies to c5 polypeptides |
| 02/11/2003 | US6518400 Polypeptide that affects the organization of chromosomes within the nucleus; heterochromatin |
| 02/11/2003 | US6518255 Administering, via multiple applications to target tissue, a dose of an adenoviral vector comprising a DNA encoding an angiogenic peptide which is an endothelial growth factor and a carrier to increase level of perfusion of blood to target |
| 02/11/2003 | US6518236 FGF homologs |
| 02/11/2003 | US6518066 Acylated Homoserine Lactone (AHL) compounds and AHL receptors derived from bacterial quorum sensing systems; inducible or repressible promotors regulate gene expression in plants and plant cells |
| 02/11/2003 | US6518065 Methods for generating polynucleotides having desired characteristics by iterative selection and recombination |
| 02/11/2003 | US6518064 Pink bollworm expression system for commercially valuable protein production |
| 02/11/2003 | US6518063 Osf2/Cbfa1 nucleic acids and methods of use therefor |
| 02/11/2003 | US6518062 Enzyme combinations for destroying proliferative cells |
| 02/11/2003 | US6518061 Interleukin-13 (IL-13); Delivery of a modified Pseudomonas exotoxin (effector molecule), attached to an interleukin, to tumor cells bearing interleukin receptors; antitumor agent |
| 02/11/2003 | US6518058 Method of preparing polypeptides in cell-free system and device for its realization |
| 02/11/2003 | US6518054 Genes encoding variants of metallo-endopeptidases that have been engineered to be resistant to prolonged boiling while having maintained their enzymatic performance at much lower temperatures. thermal stability of the metallo-endopeptidases |
| 02/11/2003 | US6518053 Thermostable esterase and its gene |
| 02/11/2003 | US6518052 Human homologue of yeast helicase and uses thereof |
| 02/11/2003 | US6518047 An isolated and purified polypeptide with inulinolytic activity having greater than 75% sequence identity with SEQ ID |
| 02/11/2003 | US6518046 DNA (RNA) encoding such chemolcine polypeptides. Moreover, a procedure for producing such polypeptides by recombinant techniques is disclosed. Also disclosed are methods for utilizing such Ck beta -9 polypeptides for the treatment of |
| 02/11/2003 | US6518044 Promoters for expressing genes in a fungal cell |
| 02/11/2003 | US6518043 Proteins suppressing proliferation of lympho-hematopoietic cells |
| 02/11/2003 | US6518042 A filamentous fungal cell, wherein a gene involved in the mismatch repair system has been inactivated and in which the gene involved in the mismatch repair system comprises a DNA sequence encoding the polypeptide sequence shown in positions |
| 02/11/2003 | US6518041 An isolated non-protein-encoding nucleic acid sequence functioning as a hormone response element which binds an androgen- or a progesterone- regulated receptor, comprising: a DNA sequence of the formula (SEQ ID NO:6) (N)x TCTCATTCTGTTCC, |
| 02/11/2003 | US6518039 Such as 7-ADCA (3-methyl-4-carboxy-7-amino-3-cephem), via production of the 7-acylated counterparts |
| 02/11/2003 | US6518035 methods of screening for a molecule that inhibits the expression or activity of a protein encoded by a target gene which affects the fitness of a cell. The methods are based on a co-culture assay, and entail culturing together two cell |
| 02/11/2003 | US6518033 The present invention relates to a method of diagnosing, classifying and grading of tumor growths and to determine whether the use of chimeric polioviruses is a proper course for the treatment of the tumors. More particularly, the method |
| 02/11/2003 | US6518032 Rapid methods for identifying modifiers of cellular apoptosis activity |
| 02/11/2003 | US6518027 Sample preparation method and a sample preparation apparatus for DNA analysis |
| 02/11/2003 | US6518023 Method of mapping restriction sites in polynucleotides |
| 02/11/2003 | US6518022 Method for enhancing the hybridization efficiency of target nucleic acids using a self-addressable, self-assembling microelectronic device |
| 02/11/2003 | US6518019 Enzymatic polypeptide for use as tools in the generation and amplification of preferential nucleotide sequences |
| 02/11/2003 | US6518018 RNA-antibody fusions and their selection |
| 02/11/2003 | US6518017 Combinatorial antisense library |
| 02/11/2003 | US6518016 Screening for the presence of a genetic defect associated with thrombosis and/or poor anticoagulant response to activated protein C (APC). The method is directed at detecting one or more mutations at one or more of the cleavage and/or binding |
| 02/11/2003 | US6518012 Method for increasing the expression of CD40 gene in tumor cells in vitro comprising the step of contacting the tumor cells with an effective amount of a deacetylase inhibitor wherein said amount of deacetylase inhibitor increases the |
| 02/11/2003 | US6517845 Detecting infection in a mammal; binding antibody to polypeptide consisting essentially of amino acid sequence 2 |
| 02/11/2003 | US6517843 Recombinant immunogen comprised of an inactivated porcine circovirus-2 |
| 02/11/2003 | US6517842 Marburg virus vaccines |
| 02/11/2003 | US6517837 Isolated nucleic acid molecules associated with colon cancer and methods for diagnosing and treating colon cancer |
| 02/11/2003 | US6517835 Growth differentiation factor-11 |
| 02/11/2003 | US6517828 C-CAM as an angiogenesis inhibitor |
| 02/11/2003 | CA2257623C Substitutes for modified starch in paper manufacture |
| 02/11/2003 | CA2257622C Substitutes for modified starch in paper manufacture |
| 02/11/2003 | CA2231409C Antibodies specific for native prpsc |
| 02/11/2003 | CA2174529C Dna encoding a hypothalamic atypical neuropeptide y/peptide yy receptor (y5) and uses thereof |
| 02/11/2003 | CA2170509C Dna encoding prostaglandin receptor ep2 |
| 02/11/2003 | CA2152667C Bone resorption assay |
| 02/11/2003 | CA2142181C Androgen regulation with dna sequences of rat probasin gene |
| 02/11/2003 | CA2139645C Immunoassays for anti-hcv antibodies using antigens with conformational epitopes |
| 02/11/2003 | CA2133843C Melanocyte stimulating hormone receptor and uses |
| 02/11/2003 | CA2078689C Chimeric antibodies with receptor binding ligands in place of their constant region |
| 02/11/2003 | CA2071537C Method and reagent for determining specific nucleotide variations |
| 02/11/2003 | CA2068871C Non-glycosylated fgf-4 and compositions containing the same |
| 02/11/2003 | CA2005704C Pneumolysin mutants and pneumococcal vaccines made therefrom |
| 02/11/2003 | CA1341419C Process for the introduction of expressible genes into plant cell genomes and agrobacterium strains carrying hybrid ti plasmid vectors useful for this process |
| 02/10/2003 | WO2002014509A1 Glycerylaldehyde-3-phosphate dehydrogenase promoter inducing cell death |
| 02/10/2003 | CA2418777A1 Glycerylaldehyde-3-phosphate dehydrogenase promoter which induces apoptosis |
| 02/08/2003 | CA2396616A1 Modified cdna for high expression levels of factor viii and its derivatives |
| 02/08/2003 | CA2354255A1 Compositions and methods for eliciting immune responses with a secretion-directed protein |
| 02/06/2003 | WO2003010506A2 Combined electronic-and photonic-based hybridation assay |
| 02/06/2003 | WO2003010338A1 Detection method of nucleic acid hybridization |
| 02/06/2003 | WO2003010337A1 Scoring system for the prediction of cancer recurrence |
| 02/06/2003 | WO2003010335A2 Il-4 receptor sequence variation associated with type 1 diabetes |
| 02/06/2003 | WO2003010334A1 Method for identifying reading frame mutations |
| 02/06/2003 | WO2003010333A2 Methods for gene disruption and uses thereof |
| 02/06/2003 | WO2003010326A2 Parallel, antiparallel, homologous or complementary binding of nucleic acids |
| 02/06/2003 | WO2003010322A1 Improved rect or recet cloning and subcloning method |
| 02/06/2003 | WO2003010321A1 Recombinant vectors derived from adeno-associated virus expressing tam67 for gene therapy |
| 02/06/2003 | WO2003010320A2 Recombinant vector derived from adeno-associated virus for gene therapy |
| 02/06/2003 | WO2003010319A2 Transformation method for obtaining marker-free plants and plants obtained therewith |
| 02/06/2003 | WO2003010318A2 Desulfoglucosinolate sulfotransferases, sequences coding the same and uses thereof for modulating glucosinolate biosynthesis in plants |
| 02/06/2003 | WO2003010317A1 Novel peptides of the respiratory syncytial virus (rsv) g protein and their use in a vaccine |
| 02/06/2003 | WO2003010316A1 Bacteriophage-mediated lysis anthrax bacteria |
| 02/06/2003 | WO2003010315A1 Abca7 splicing variant |
| 02/06/2003 | WO2003010314A2 Gmg-2 polynucleotides and polypeptides and uses thereof |
| 02/06/2003 | WO2003010313A1 Novel diphtheria anatoxins and their use as carrier |
| 02/06/2003 | WO2003010312A2 Nucleic acid sequences encoding enantioselective amidases |
| 02/06/2003 | WO2003010311A2 Process for preparing variant polynucleotides |